Research / AVGO / Fundamental state Inspectable configuration
State dimensions Filing 0001730168-20-000109 General Corporate
Debt relative to revenue 100th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.debt_to_revenue
797.77% · OPTIONAL · VALID
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.58% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
55.96% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
4.08% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 38th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
16.60% · OPTIONAL · VALID
Gross margin 75th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_margin
55.54% · CORE · VALID
Operating margin 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.operating_margin
13.34% · CORE · VALID
R&D intensity 88th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
22.10% · OPTIONAL · VALID
SBC intensity 50th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
9.00% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 23 states Self-history eligible
Feb 3, 2019 0/8 normalized Level 3 May 5, 2019 0/9 normalized Level 3 Aug 4, 2019 0/9 normalized Level 3 Nov 3, 2019 0/9 normalized Level 3 Feb 2, 2020 0/9 normalized Level 3 May 3, 2020 6/9 normalized Level 3 Aug 2, 2020 8/9 normalized Level 3 Nov 1, 2020 8/9 normalized Level 3 Jan 31, 2021 8/9 normalized Level 3 May 2, 2021 9/9 normalized Level 3 Aug 1, 2021 9/9 normalized Level 3 Oct 31, 2021 9/9 normalized Level 3 Jan 30, 2022 9/9 normalized Level 3 May 1, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 30, 2022 8/8 normalized Level 3 Jan 29, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Aug 2, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 762.43%
Current 797.77%
Delta 35.34% Capex Intensity Increased
Previous 1.84%
Current 2.58%
Delta 0.73% Cash Generation Increased
Previous 39.64%
Current 55.96%
Delta 16.32% Growth Increased
Previous 1.19%
Current 4.08%
Delta 2.89% Inventory Pressure Increased
Previous 16.11%
Current 16.60%
Delta 0.48% Margin Decreased
Previous 55.72%
Current 55.54%
Delta -0.18% Profitability Increased
Previous 12.19%
Current 13.34%
Delta 1.15% R And D Intensity Increased
Previous 22.00%
Current 22.10%
Delta 0.10% Sbc Intensity Decreased
Previous 9.30%
Current 9.00%
Delta -0.30% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.